Interactive rheumatology education has flourished online thanks to grassroots efforts & ACR support…... [Read More]
Susan Bernstein is a freelance journalist based in Atlanta. She earned a Bachelor of Arts degree in English from the University of Florida in Gainesville, Fla. Susan has worked as a professional journalist, writer, book author and editor for 25 years. She served in full-time positions with both the Arthritis Foundation and the American College of Rheumatology. She began working as a freelance journalist in 2011. Susan is the author of numerous Web and print articles on a variety of medical topics and is the author of three patient health books published by the Arthritis Foundation.
Articles by Susan Bernstein
The ACR Extends Its Global Outreach with a New Task Force
In 2019, the ACR created a Global Strategy Task Force to establish and oversee a cohesive approach to expanding its global impact in education, training and research through increased engagement with international partners. Just as the task force met in February 2020, the world was plunged into the COVID-19 pandemic. The concept of global collaboration… [Read More]
Adapting Care for Pediatric Patients & Parents During the Pandemic: Q&A with Sangeeta Sule, MD, PhD
Social distancing and telemedicine are creating unique challenges for pediatric rheumatologists to care for their patients—many of whom are 5 years old or younger. Sangeeta Sule, MD, PhD, discusses how her clinic is adapting…... [Read More]
Patients Need Psychosocial Support Now More Than Ever: Q&A with Adena Batterman, MSW, LCSW
How are rheumatology professionals affected by the physical distancing and other challenges presented by COVID-19? The Rheumatologist interviewed Adena Batterman, MSW, LCSW, senior manager of inflammatory arthritis support and education programs at the Hospital for Special Surgery, New York, to discuss how the pandemic has changed the way she and her staff maintain continuity of… [Read More]
New Processes May Stick Around After the Pandemic: Q&A with Wendy Ramey, BSPharm, RPh, CSP
How are COVID-19 and physical distancing restrictions at work affecting rheumatology professionals? The Rheumatologist interviewed clinical pharmacist Wendy Ramey, BSPharm, RPh, CSP, to discuss how the pandemic has changed the way her staff supports rheumatologists at the University of Kentucky Specialty Pharmacy and Infusion Services, Lexington. Ms. Ramey describes how these unprecedented times affect patients,… [Read More]
A Transition to 90% Telemedicine: Q&A with Karim Masri, MD
How are COVID-19 and current restrictions on physical distancing affecting rheumatologists? The Rheumatologist interviewed Karim Masri, MD, to ask how the pandemic has changed the way he and his clinic staff deliver patient care, and how these unprecedented times affect patients, staff and life outside the office. Dr. Masri is a practicing rheumatologist at Bon… [Read More]
The Personal Side of COVID-19: Q&A with Philip A. Waller, MD
The outbreak of the SARS-CoV-2 virus is disrupting rheumatology clinics and practices all over the world. In the U.S., many providers are turning to telemedicine to care for their patients, but struggles remain. Philip A. Waller, MD, who practices at Accurate Clinical Research, Houston, spoke with The Rheumatologist about how the pandemic is affecting his… [Read More]
Providing the Best Care: Rheumatologists & Professionals Adapt to COVID-19
The new landscape for rheumatologists includes telemedicine, kids out of school and infection-prevention protocols. During the current pandemic, the practice of medicine, research and daily lives are changing to keep providers and patients safe…... [Read More]
Old Drug, New Interest: COVID-19 Spurs Hydroxychloroquine Supply Concerns for Rheumatic Disease Patients
After a study investigated if hydroxycholoroquine (HCQ) benefits COVID-19 patients, the drug—used to treat SLE and RA patients—began running out in pharmacies around the U.S. ACR leaders have asked the FDA to increase monitoring of the HCQ supply…... [Read More]
FDA Update: New Drug Approvals, New & Expanded Indications, & More
ATLANTA—New drug approvals, new and expanded drug indications, and important safety and other updates relevant for rheumatologists were presented by three physicians from the U.S. Food & Drug Administration (FDA) on Nov. 11 at the 2019 ACR/ARP Annual Meeting. New JAK Inhibitor Approved for RA On Aug. 16, 2019, the FDA approved upadacitinib (Rinvoq), an… [Read More]
- 1
- 2
- 3
- …
- 18
- Next Page »